Literature DB >> 25579611

Belgian guidelines for budget impact analyses.

M Neyt, I Cleemput, S Van De Sande, N Thiry.   

Abstract

OBJECTIVES: To develop methodological guidelines for budget impact analysis submitted to the Belgian health authorities as part of a reimbursement request.
METHODS: A review of the literature was performed and provided the basis for preliminary budget impact guidelines. These guidelines were improved after discussion with health economists from the Belgian Health Care Knowledge Centre (KCE) and different Belgian stakeholders from both government and industry. Preliminary guidelines were also discussed in a workshop with health economists from The German Institute for Quality and Efficiency in Healthcare. Finally, the guidelines were also externally validated by three external experts.
RESULTS: The guidelines give explicit guidance for the following components of a budget impact analysis: perspective of the evaluation, target population, comparator, costs, time horizon, modeling, handling uncertainty and discount rate. Special attention is given to handling varying target population sizes over time, applying a time horizon up to the steady state instead of short-term predictions, and similarities and differences between budget impact analysis and economic evaluations.
CONCLUSION: The guidelines provide a framework for both researchers and assessors to set up budget impact analyses that are transparent, relevant, of high quality and apply a consistent methodology. This might improve the extent to which such evaluations can reliably and consistently be used in the reimbursement decision making process.

Keywords:  Budget impact,; Economic evaluations,; Guidelines,; Reimbursement

Mesh:

Year:  2015        PMID: 25579611     DOI: 10.1179/2295333714Y.0000000118

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  13 in total

Review 1.  A Methodological Review of US Budget-Impact Models for New Drugs.

Authors:  Josephine Mauskopf; Stephanie Earnshaw
Journal:  Pharmacoeconomics       Date:  2016-11       Impact factor: 4.981

Review 2.  The French National Authority for Health (HAS) Guidelines for Conducting Budget Impact Analyses (BIA).

Authors:  Salah Ghabri; Erwan Autin; Anne-Isabelle Poullié; Jean Michel Josselin
Journal:  Pharmacoeconomics       Date:  2018-04       Impact factor: 4.981

3.  Cost-effectiveness of a smartphone Application for Tinnitus Treatment (the CATT trial): a study protocol of a randomised controlled trial.

Authors:  Annick Gilles; Sarah Michiels; Sara Demoen; Laure Jacquemin; Annick Timmermans; Vincent Van Rompaey; Olivier Vanderveken; Hanne Vermeersch; Iris Joossen; Julie Van Eetvelde; Winfried Schlee; Wim Marneffe; Janis Luyten
Journal:  Trials       Date:  2022-05-23       Impact factor: 2.728

4.  Does the inclusion of societal costs change the economic evaluations recommendations? A systematic review for multiple sclerosis disease.

Authors:  B Rodríguez-Sánchez; S Daugbjerg; L M Peña-Longobardo; J Oliva-Moreno; I Aranda-Reneo; A Cicchetti; J López-Bastida
Journal:  Eur J Health Econ       Date:  2022-05-20

5.  Partial economic evaluation of clinical pharmacy interventions on the prescription of direct oral anticoagulants in a teaching hospital.

Authors:  C Declaye; A L Sennesael; A S Larock; A Spinewine; B Krug
Journal:  Eur J Hosp Pharm       Date:  2017-01-02

Review 6.  A methodological review of national and transnational pharmaceutical budget impact analysis guidelines for new drug submissions.

Authors:  Naghmeh Foroutan; Jean-Eric Tarride; Feng Xie; Mitchell Levine
Journal:  Clinicoecon Outcomes Res       Date:  2018-11-26

Review 7.  A Comparison of Pharmaceutical Budget Impact Analysis (BIA) Recommendations Amongst the Canadian Patented Medicine Prices Review Board (PMPRB), Public and Private Payers.

Authors:  Naghmeh Foroutan; Jean-Eric Tarride; Feng Xie; Fergal Mills; Mitchell Levine
Journal:  Pharmacoecon Open       Date:  2019-12

8.  Study protocol: a single-blind, multi-center, randomized controlled trial comparing dynamic intraligamentary stabilization, internal brace ligament augmentation and reconstruction in individuals with an acute anterior cruciate ligament rupture: LIBRƎ study.

Authors:  Christiaan H W Heusdens; Katja Zazulia; Ella Roelant; Lieven Dossche; Damien van Tiggelen; Johan Roeykens; Elke Smits; Johan Vanlauwe; Pieter Van Dyck
Journal:  BMC Musculoskelet Disord       Date:  2019-11-18       Impact factor: 2.362

9.  National Methodological Guidelines to Conduct Budget Impact Analysis for Health Technology Assessment in India.

Authors:  Shankar Prinja; Yashika Chugh; Kavitha Rajsekar; V R Muraleedharan
Journal:  Appl Health Econ Health Policy       Date:  2021-06-29       Impact factor: 2.561

10.  The Quality of EBM Sources Perceived By Belgian Family Physicians.

Authors:  Laurence de Fernelmont; Sven Van Laere; Dirk Devroey
Journal:  Open Access Maced J Med Sci       Date:  2018-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.